Sarah has over two decades of sales, marketing, and general management experience in CPG, with particular expertise in the launch and management of health and wellness brands. Sarah’s career has been split between working on the brand manufacturer side with companies such as Schering-Plough (now Bayer | Consumer Health) and Crayola, and consulting for large and small companies independently as well as with Market Performance Group's Strategy and Business Consulting group. Clients have included Bayer, Sanofi, Galderma, Orasure, HRA Pharma (now Perrigo), Foundation Consumer Healthcare, and Emergent BioSolutions.

Sarah's long list of accomplishments include launching category-changing products, including Claritin's Rx to OTC switch (the first OTC non-sedating antihistamine), NARCAN® Nasal Spray's Rx to OTC switch (the first OTC opioid reversal product), IntelliSwab (COVID diagnostic test launched early in the pandemic for home use), and Opill's Rx to OTC switch (the first OTC oral contraceptive).

Sarah also has helped small brands gain a foothold in the competitive US retail environment. Sarah enjoys the big picture strategy as well as the focus on minutia that every successful brand requires.